Solas BioVentures β Full Portfolio
31 tracked investments Β· listed companies and verified rows first
Shionogi is a pharmaceutical company that discovers and develops medicines for challenging human diseases, including antibiotics and treatments for HIV, influenza, and COVID-19.
BiotechHealthtech
Co-investorsAdvent Life Sciences
Tvardi Therapeutics is a clinical-stage biopharmaceutical company developing oral small molecule STAT3 inhibitors to treat inflammatory and proliferative diseases.
BiotechHealthtechHouston, US
David J. Tweardy(Executive Officer, Director)Imran Alibhai(Chief Executive Officer)inRonald DePinho(Director)Josef Schoell(Executive Officer)Jeffrey L. Ives(Director)Joseph W. Stauffer(Executive Officer)
Co-investorsShangBay Capital LLC
Stimdia Medical develops neuromodulation technologies, with a leadership team focused on clinical and regulatory affairs and R&D in critical care and pulmonary medicine.
BiotechDeep TechHealthtechMedical DevicesEdina, US
Jay Katarincic(Founder, Stimdia Medical; Director, Draper Triangle Ventures)inJim Bullock(Founder, Stimdia Medical; Board Chairman)Patrick Wethington(Executive Officer, Director)inAllen Meacham(President and Chief Executive Officer)inBrad Swatfager(Chief Financial Officer)Kristen Lechleiter(Vice President, Clinical and Regulatory Affairs)in
Co-investorsFresenius Medical Care Ventures
Francis Medical is a medical device company developing minimally invasive urological cancer treatments using water vapor ablation technology, initially focused on prostate cancer with its Vanquish Water Vapor Ablation System.
BiotechDigital HealthHealthtechMedical DevicesMaple Grove, US
Michael Hoey(Founder)inMichael Kujak(Executive Officer, Director)Christopher Dixon(Chief Medical Officer)in
BoardAndrew Cleeland(Director)Jan Garfinkle(Director)inDavid Adair(Director)in
Board seatMichael HoeyΒ· per SEC Form D
Co-investorsArboretum Ventures
Advanced Catheter Therapies develops the Pressana Occlusion Perfusion Catheter, a medical device for targeted endovascular delivery of therapeutic agents to treat peripheral arterial disease and prevent limb amputation.
BiotechHealthtechMedical Devices
Paul J. Fitzpatrick(Chief Executive Officer)
Co-investorsChattanooga Renaissance FundInnova Memphis, Inc.
Arctx Medical develops an investigational cooling therapy device designed to treat acute pancreatitis by reducing pancreatic inflammation through localized temperature control.
BiotechDigital HealthHealthtechMedical Devices
Co-investorsScientific Health Development
Arrivo Bio develops novel, disease-modifying medicines targeting the root cause of hard-to-treat diseases for which few effective treatment options exist.
BiotechMedical Devices
Co-investorsOrlando Health VenturesRex Health Ventures
Aurenar develops a non-invasive, ear-worn neuromodulation wearable that stimulates a nerve in the ear to boost the body's natural control of inflammation, targeting complications in intensive care unit patients.
HardwareHealthtechMedical Devices
Eric Leuthardt(Chief Executive Officer & Founder)inJenna Gorlewicz(Chief Technology Officer & Founder)inAnna Huguenard(Chief Medical Officer & Founder)inJesse Wheeler(Chief Operations Officer)inRyan Kight(Chief Financial Officer)in
Co-investorsKaleida CapitalDeep Future
Baebies develops multifunctional syndromic diagnostic testing using proprietary digital microfluidics, integrating molecular, immunoassay, chemistry, and coagulation testing into a single compact platform (FINDER) that runs on small-volume samples.
BiotechDeep TechDigital HealthHealthtechMedical DevicesResearch Triangle Park, US
Vamsee Pamula(Executive Officer, Director)in
BoardDennis Sacha(Director)William A. Hawkins(Director)
Co-investorsDuke Capital PartnersIAG Capital PartnersRex Health VenturesVentureSouth
Basking Biosciences develops therapeutics for thrombosis, vascular biology, and ischemic disease.
BiotechDigital HealthHealthtechMedical DevicesCary, US
Shahid Nimjee(Co-founder, Chief Scientific Officer and Stroke Clinical Lead)inBruce Sullenger(Co-founder)Julia Owens(Executive Officer, Director, Promoter)inRichard Shea(Executive Officer, Director, Promoter)in
BoardHannah Chang(Director)Aiden Aceves(Director)in
Co-investorsARCH Venture PartnersInsight PartnersBroadview VenturesRev1 VenturesRTW Investments L.P.
CardioNXT develops cardiac mapping and navigation technology, including its iMap System, used to navigate next-generation pulsed field ablation (PFA) catheters for cardiac procedures such as pulmonary vein isolation and left atrium mapping.
HardwareHealthtechMedical DevicesWestminster, US
Donald Conty(Executive Officer, Director, Promoter)Jerome Edwards(Executive Officer, Director, Promoter)
BoardThomas Kurian(Director, Promoter)
Cryosa develops an incisionless medical treatment that uses controlled cooling to reduce tissue and open airways.
BiotechHealthtechMedical DevicesArden Hills, US
Laura Stoltenberg(Executive Officer, Director)in
BoardDavid Belitz(Director)inDoug French(Director)James Eadie(Director)Donald Gonzales(Founder and Chief Medical Officer)
Co-investorsBrightstone Venture Capital
Dimension Bio is a biotechnology company that designs and manufactures regenerative therapeutics using its BioNidumβ’ platform to restore tissue function lost to disease, trauma, or aging.
BiotechHealthtechNew MaterialsChicago, US
Caralynn Nowinski Collens, M.D.(Co-founder & CEO)inRamille Shah, Ph.D.(Co-founder & CSO)Ramille Shah(Director)Caralynn Collens(Executive Officer, Director)inAdam Jakus(Executive Officer, Director)in
BoardRima Chakrabarti(Director)in
Co-investorsBetter Ventures Central LlcLofty VenturesPathway BioventuresPortal InnovationsKdT VenturesPrime Movers Lab
.png)
EirSystems builds medication management infrastructure for healthcare providers and EHR platforms, focusing on electronic medication administration records and opioid prescription monitoring across long-term care, behavioral health, and post-acute settings.
Digital HealthEnterprise SoftwareHealthtechMedical DevicesSaaSChattanooga, US
Robert Newman(Executive Officer, Director, Promoter)inRyan Seaberg(Co-Founder)Tyler Seaberg(Executive Officer, Director, Promoter)
Co-investorsAtlanta Technology AngelsChain Reaction
Develops an at-home device that measures bladder and urinary symptoms in men and generates a report for healthcare providers to support clinical decisions.
Digital HealthHardwareMedical DevicesKnoxville, US
Ryan Wilemsen(Executive Officer)Stephen Grady Arnold(Executive Officer)Britton Alan Garrett(Executive Officer, Director)John Green(Executive Officer)Brent Laing(Executive Officer, Director)Brad Rouse(Director)
Co-investorsJumpstart Capital
Intershunt develops the Dynama System (also known as the PAS-C System), an investigational interatrial shunting device designed to create a pathway in the heart's upper chambers to reduce elevated left atrial pressure and relieve heart failure symptoms.
HardwareHealthtechMedical DevicesFridley, US
Harlan Lee Sorkin(Executive Officer, Director)Gil M. Vardi(Director)
BoardDenis Harrington(Director)inDavid Adair(Director)inJim Bullock(Director)
Ischemia Care operates a CLIA-certified laboratory that develops blood tests for stroke patients using RNA expression analysis to determine stroke cause and improve clinical outcomes.
AI & Machine LearningDigital HealthHealthtechMedical DevicesOxford, US
Jeffrey June(Executive Officer, Director)Teresa June(Executive Officer)in
Co-investorsBroadview VenturesEarly Stage Partners, LP
Jazz Pharmaceuticals is a biopharmaceutical company developing treatments for rare diseases and cancers, with a focus on oncology and biomarker-driven therapies such as those targeting HER2-expressing cancers.
BiotechHealthtech
Co-investorsLongitude CapitalProspect Venture PartnersRex Health Ventures
Knopp Biosciences is a privately held company that manages a portfolio of future milestone payments and product royalties from drug pipelines it sold or spun off in 2022.
BiotechHealthtechPittsburgh, US
Thomas V. Petzinger, Jr.(LLC Manager)Michael E. Bozik(LLC Manager)Steven Dworetzky(Executive Officer)
BoardBenjamin A. Gomez(LLC Manager)Jeffrey S. McCormick(LLC Manager)inGregory T. Hebrank(LLC Manager)
Co-investorsSaturn Partners
NX Prenatal is a molecular diagnostics company developing exosome-based liquid biopsy assays that detect adverse pregnancy conditions such as preterm birth, preeclampsia, and placenta accreta.
BiotechDigital HealthFemTechHealthtechLouisville, US
Paul Kortschak(Chief Executive Officer)GAIL PAGE(Executive Officer, Director)BRIAN BROHMAN(Executive Officer, Director)ROBERT SAUNDERS(Director)KEVIN BRAMER(Director)ALAN MACK(Director)
Co-investorsBelle Impact FundMindshift CapitalGolden SeedsPortfolia
Olympus develops medical technologies and solutions for detecting and treating disease.
HardwareHealthtechMedical Devices
Pathware provides real-time biopsy quality assessment technology for pathologists to determine sample adequacy on-site, reducing repeat procedures and unnecessary surgeries.
AI & Machine LearningHealthtechMedical Devices
Co-investorsCANTILEVER INVESTORSInnoventures IowaNext Level VenturesLevel Eight Ventures
Phenomics Health builds a medication-response intelligence platform that combines high-complexity clinical laboratory testing, pharmacogenomics, pharmacometabolomics, and AI-enabled analytics to support precision prescribing and medication decisions.
AI & Machine LearningDigital HealthHealthtechPlymouth, US
Brian D. Athey(Co-founder)Daniel Jasewicz(Company Leadership (Strategy & Commercialization))inGerry Higgins(Scientific Strategy Lead)inAlex Ade(Technology & Data Science Lead)inPamela Weir(Director)Lew Wallace(Director)
PreTel develops wearable uterine electromyography sensors and AI-powered analysis software to monitor uterine contractions during pregnancy, enabling early detection of preterm labor, assessment of false labor, and guided Pitocin dosing during labor induction for obstetric care providers.
AI & Machine LearningFemTechMedical DevicesChattanooga, US
Roger Young(Chief Medical Officer / Founder)Marc Finch(CEO)
BoardMark A Samuels(Chairman)
Co-investorsTech Square Ventures
Vektor Medical develops patient-specific computational models of cardiac electrophysiology to support the diagnosis and treatment of heart arrhythmias.
AI & Machine LearningDigital HealthHealthtechMedical DevicesCarlsbad, US
Chris Villongco(Head of Technology / CTO)inRob Krummen(CEO (formerly President & COO))inKelly Perez(Head of Finance)inAlexander Michael Monko(Executive Officer, Director)
Co-investorsTVM Capital Life Science
Other
Tracked investments with no reachable website or further public details β typically companies that wound down, renamed, or were absorbed.
Bio 54, LLCAegeamedicalArrivo BioVenturesRediscoveryls
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.